These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35860905)

  • 1. Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling.
    Brown NE; Jones A; Hunt BG; Waltz SE
    Prostate; 2022 Nov; 82(15):1422-1437. PubMed ID: 35860905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation.
    Brown NE; Paluch AM; Nashu MA; Komurov K; Waltz SE
    Neoplasia; 2018 Sep; 20(9):917-929. PubMed ID: 30121008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy.
    Al-Janabi H; Moyes K; Allen R; Fisher M; Crespo M; Gurel B; Rescigno P; de Bono J; Nunns H; Bailey C; Junker-Jensen A; Muthana M; Phillips WA; Pearson HB; Taplin ME; Brown JE; Lewis CE
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39060021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer.
    Chen S; Cai C; Sowalsky AG; Ye H; Ma F; Yuan X; Simon NI; Gray NS; Balk SP
    Cancer Res; 2018 Sep; 78(18):5203-5215. PubMed ID: 30012673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.
    Cheng Q; Butler W; Zhou Y; Zhang H; Tang L; Perkinson K; Chen X; Jiang XS; McCall SJ; Inman BA; Huang J
    Eur Urol; 2022 May; 81(5):446-455. PubMed ID: 35058087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer.
    Batth I; Yun H; Hussain S; Meng P; Osmulski P; Huang TH; Bedolla R; Profit A; Reddick R; Kumar A
    Oncotarget; 2016 Mar; 7(12):14048-63. PubMed ID: 26872377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.
    Batth IS; Yun H; Kumar AP
    Mol Carcinog; 2015 Oct; 54(10):937-46. PubMed ID: 26152593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer.
    El-Kenawi A; Dominguez-Viqueira W; Liu M; Awasthi S; Abraham-Miranda J; Keske A; Steiner KK; Noel L; Serna AN; Dhillon J; Gillies RJ; Yu X; Koomen JM; Yamoah K; Gatenby RA; Ruffell B
    Cancer Res; 2021 Nov; 81(21):5477-5490. PubMed ID: 34301759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of the cellular secretory milieu overrides androgen dependence of in vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor.
    Patki M; Huang Y; Ratnam M
    Biochem Biophys Res Commun; 2016 Jul; 476(2):69-74. PubMed ID: 27179779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression.
    Sullivan C; Brown NE; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
    Mol Cancer Res; 2020 Aug; 18(8):1244-1254. PubMed ID: 32439702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
    O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
    Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the androgen receptor signaling pathway in advanced prostate cancer.
    Chung C; Abboud K
    Am J Health Syst Pharm; 2022 Jul; 79(15):1224-1235. PubMed ID: 35390118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages.
    Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Cohen P; Aronson WJ
    Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):127-135. PubMed ID: 31439889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.
    Qin J; Lee HJ; Wu SP; Lin SC; Lanz RB; Creighton CJ; DeMayo FJ; Tsai SY; Tsai MJ
    J Clin Invest; 2014 Nov; 124(11):5013-26. PubMed ID: 25295534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.
    Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
    Hum Cell; 2016 Jan; 29(1):22-9. PubMed ID: 26250899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer.
    Alvarez-Arzola R; Bancaro N; Lai P; Attanasio G; Pellegrini L; Troiani M; Colucci M; Mosole S; Pasquini E; Alimonti A; Mesa C
    Cell Commun Signal; 2023 Apr; 21(1):76. PubMed ID: 37055829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.
    Lubik AA; Nouri M; Truong S; Ghaffari M; Adomat HH; Corey E; Cox ME; Li N; Guns ES; Yenki P; Pham S; Buttyan R
    Int J Cancer; 2017 Jan; 140(2):358-369. PubMed ID: 27672740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adrenal derived androgens in castration resistant prostate cancer.
    Barnard M; Mostaghel EA; Auchus RJ; Storbeck KH
    J Steroid Biochem Mol Biol; 2020 Mar; 197():105506. PubMed ID: 31672619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46.
    Liu YN; Niu S; Chen WY; Zhang Q; Tao Y; Chen WH; Jiang KC; Chen X; Shi H; Liu A; Li J; Li Y; Lee YC; Zhang X; Huang J
    Clin Cancer Res; 2019 Jul; 25(13):4128-4140. PubMed ID: 30962287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis.
    Xu Z; Ma T; Zhou J; Gao W; Li Y; Yu S; Wang Y; Chan FL
    Theranostics; 2020; 10(9):4201-4216. PubMed ID: 32226548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.